OBI Pharma, Inc.
 |
| Company type | Publicly traded |
|---|---|
| TWSE: 4174 | |
| Industry | pharmaceuticals |
| Founded | 2002 |
| Headquarters | , |
| Revenue |  |
| Website | www |
OBI Pharma, Inc.(Chinese:台灣浩鼎生技股份有限公司) (TWSE: 4174) is a biopharmaceutical company, based in Nangang District, Taipei City, Taiwan, R.O.C..
History
This company was formerly a subsidiary of Optimer Pharmaceuticals.
In 2002, Chi-Huey Wong has been currently involved in possible insider trading scandal of the Taiwan-based biotech company OBI Pharma, Inc.(Chinese:台灣浩鼎生技股份有限公司), formerly a subsidiary of Optimer Pharmaceuticals, which has since been purchased by Cubist Pharmaceuticals. Wong had twice attempted to resign his position as the head of the Academia Sinica because of the scandal. Both requests have been denied by the president of Republic of China (Taiwan). He is currently on medical leave in southern California.
On 9 Feb 2007, its parent company Optimer Pharmaceuticals can buy/sell on Nasdaq Stock Exchange. At that time, its share price was USD 8.50 per share.
On 15 May 2012, OBI Pharma, Inc. was approved to become a public company in Taiwan.
On 23 Mar 2015, it can do transaction formally on OTC in Taiwan R.O.C.